Financhill
Sell
22

VOR Quote, Financials, Valuation and Earnings

Last price:
$13.20
Seasonality move :
-36.85%
Day range:
$12.25 - $13.80
52-week range:
$2.62 - $65.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.13x
Volume:
1M
Avg. volume:
1M
1-year change:
-56.13%
Market cap:
$90M
Revenue:
--
EPS (TTM):
-$381.91

Earnings Data

Next earnings date for VOR
Mar 26
2026
Most recent earnings per share
-$121.63
Missed by $117.53
(Nov 13/2025)
Consensus Estimate
-$4.10
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VOR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$1.00 --
03/26/2026 Q4 -- -- -- -$1.00 --
11/13/2025 Q3 -- -- -$121.63 -$4.10 -$117.53
08/13/2025 Q2 -- -- -$251.24 -$11.80 -$239.44
05/08/2025 Q1 -- -- -$0.26 -$4.16 $3.90
03/20/2025 Q4 -- -- -$8.78 -$6.13 -$2.65
11/07/2024 Q3 -- -- -$0.40 -$8.09 $7.68
08/08/2024 Q2 -- -- -$0.41 -$8.29 $7.88
05/09/2024 Q1 -- -- -$0.45 -$7.63 $7.18
03/20/2024 Q4 -- -- -$0.39 -$9.94 $9.56
11/07/2023 Q3 -- -- -$0.49 -$9.17 $8.68
08/10/2023 Q2 -- -- -$0.45 -- --
05/11/2023 Q1 -- -- -$0.43 -- --
03/23/2023 Q4 -- -- -$0.51 -- --
11/10/2022 Q3 -- -- -$0.63 -- --
08/11/2022 Q2 -- -- -$0.58 -- --
05/12/2022 Q1 -- -- -$0.61 -- --
03/14/2022 Q4 -- -- -$0.49 -- --
11/10/2021 Q3 -- -- -$0.50 -- --
08/09/2021 Q2 -- -- -$0.50 -- --
05/06/2021 Q1 -- -- -$0.41 -- --
12/31/2020 Q4 -- -- -$0.48 -- --
09/30/2020 Q3 -- -- -$0.38 -- --
06/30/2020 Q2 -- -- -$0.24 -- --
03/31/2020 Q1 -- -- -$0.23 -- --
12/31/2019 Q4 -- -- -$0.12 -- --
09/30/2019 Q3 -- -- -$0.11 -- --

Vor Biopharma, Inc. Earnings Questions

  • How Much did Vor Biopharma, Inc. Generate in Revenue Last Quarter?

    Vor Biopharma, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vor Biopharma, Inc. Beat Earnings Last Quarter?

    Vor Biopharma, Inc. announced earnings per share of -$121.63 which represents a miss of analyst forecast a -$4.10 per share.

  • Is Vor Biopharma, Inc. Profitable?

    Vor Biopharma, Inc. reported -$2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Vor Biopharma, Inc. EPS Next Year?

    Vor Biopharma, Inc.'s earnings are forecast to decrease from -$34.03 per share to -$4.61 per share next year representing a decrease of -86.46%.

  • When is Vor Biopharma, Inc.'s Earnings Date?

    Vor Biopharma, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock